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Abstract
Background: Whether waist circumference provides clinically meaningful information not delivered by body-mass index
regarding prediction of cause-specific death is uncertain.
Methods: We prospectively examined waist circumference (WC) and body-mass index (BMI) in relation to cause-specific
death in 225,712 U.S. women and men. Cox regression was used to estimate relative risks and 95% confidence intervals (CI).
Statistical analyses were conducted using SAS version 9.1.
Results: During follow-up from 1996 through 2005, we documented 20,977 deaths. Increased WC consistently predicted risk
of death due to any cause as well as major causes of death, including deaths from cancer, cardiovascular disease, and non-
cancer/non-cardiovascular diseases, independent of BMI, age, sex, race/ethnicity, smoking status, and alcohol intake. When
WC and BMI were mutually adjusted in a model, WC was related to 1.37 fold increased risk of death from any cancer and
1.82 fold increase risk of death from cardiovascular disease, comparing the highest versus lowest WC categories.
Importantly, WC, but not BMI showed statistically significant positive associations with deaths from lung cancer and chronic
respiratory disease. Participants in the highest versus lowest WC category had a relative risk of death from lung cancer of
1.77 (95% CI, 1.41 to 2.23) and of death from chronic respiratory disease of 2.77 (95% CI, 1.95 to 3.95). In contrast, subjects in
the highest versus lowest BMI category had a relative risk of death from lung cancer of 0.94 (95% CI, 0.75 to 1.17) and of
death from chronic respiratory disease of 1.18 (95% CI, 0.89 to 1.56).
Conclusions: Increased abdominal fat measured by WC was related to a higher risk of deaths from major specific causes,
including deaths from lung cancer and chronic respiratory disease, independent of BMI.
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Introduction
Body-mass index (body weight in kilograms divided by the
square of height in meters, BMI) is currently the most frequently
used and widely accepted method to classify medical risk
according to weight status. BMI is a useful measure of adiposity
in young and middle-aged adults [1]. However, an important
limitation of the BMI is its inability to distinguish between fat mass
and fat-free mass, which show opposing relations with health risk
[2]. In addition, the validity of BMI as an indicator of fatness in
elderly persons is limited [3] because fat-free mass decreases with
aging, even without a change in overall weight [4].
In contrast, waist circumference (WC) represents a measure of
adiposity that takes into account the accumulation of abdominal fat.
WC is simple to measure and interpret and it is highly correlated with
visceral fat as assessed by computed tomography [5]. WC has
increased significantly in United States (U.S.) women and men in
recent decades, a secular trend that mirrors the development of
generalized adiposity in this country. The potentially greater relevance
of WC than BMI for predicting adverse health conditions in the
elderly is underscored by the observation that fat mass accumulates
intra-abdominally with age [6]. Older age groups have experienced a
greater increase in abdominal obesity than younger age groups [7].
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18582In a large, contemporary cohort of U.S. women and men, we
examined the relations of general and abdominal adiposity to
death from specific causes. Our study differs from most previous
investigations in quantifying the dose-response associations
according to both WC and BMI.
Materials and Methods
Study population
The NIH-AARP Diet and Health Study began in 1995–1996
when 566,407 AARP members aged 50 to 71 years and residing in
one of six U.S. states (CA, FL, LA, NJ, NC, and PA) or two
metropolitan areas (Atlanta, GA, and Detroit, MI) satisfactorily
completeda baselinequestionnaire on their medical history,current
body weight, height, smoking habits, and diet [8]. In 1996–1997, a
second questionnaire requesting additional information on abdom-
inal circumference was sent to baseline questionnaire respondents
within six months and was returned by 59.5 percent of participants.
TheSpecialStudiesInstitutional ReviewBoardoftheU.S.National
Cancer Institute accepted return of the questionnaires as an
indication of voluntary participation, in lieu of signed consent.
Population for analysis
To incorporate the WC data collected on the second
questionnaire, our analysis included the 234,182 potentially
eligible participants who provided complete information regarding
their WC on the second questionnaire. We excluded individuals
with a BMI less than 18.5 kg/m
2 (n=2,720) because very low
weight measured at older age is likely to reflect leanness as a
consequence of chronic illness. We also excluded participants with
a BMI greater than 60 (n=65). We excluded subjects with missing
information on smoking (n=2,548). We also excluded persons
with extreme values (beyond three inter-quartile ranges of the 75
th
and 25
th percentiles) for WC (n=3,137). The remaining analytical
cohort comprised of 225,712 subjects.
Cohort follow-up
Cohort members were followed-up from November 8, 1996
through December 31, 2005 by annual linkage of the cohort to the
National Change of Address database maintained by the U.S.
Postal Service and through processing of undeliverable mail, other
address change update services, and directly from cohort
members’ notifications. For matching purposes, we have virtually
complete data on first and last name, address history, gender, and
date of birth. Social Security number is available for 85 percent of
our cohort.
Mortality ascertainment
Vital status is ascertained by annual linkage to the Social
Security Administration Death Master File in the U.S. [9]
Verification of vital status and cause of death information is
provided by follow-up searches of the National Death Index (NDI)
Plus. We estimate that our mortality ascertainment is greater than
93 percent complete [9,10]. Cohort maintenance also involves
periodic linkage to the eleven state cancer registries serving our
cohort [eight baseline states plus three most common states of re-
location (TX, AZ, and NV) during follow-up] [11].
Assessment of anthropometric variables
WC was assessed in the second questionnaire using a pictured
instruction. Participants were requested to measure their waist
with a tape measure one inch above the navel while standing and
to report values to the nearest quarter inch. Participants for whom
a tape measure was not available were asked to leave a blank
response. Information on body weight and height was requested in
the baseline questionnaire.
For the analyses of WC, participants were divided into the
following categories: normal (women: less than 80 centimeters;
men: less than 94 centimeters), action level 1 (women: 80 to
87 centimeters; men: 94 to 101 centimeters), and action level 2
(women: 88 centimeters or higher; men: 102 centimeters or
higher). Those categories incorporate the WHO cut-points of
88 centimeters or higher for women and 102 centimeters or
higher for men that define a large WC [12] and they correspond to
the action levels proposed by Lean et al. [13] We also created a
more extreme group of WC of 96 centimeters or higher for
women and 118 centimeters or higher for men to investigate a
broader range of WC in relation to death. The group of subjects
Table 1. Relative risk of death from any cause according to waist circumference and body mass index.
Death from any cause
Waist circumference (cm)
,80 (women); ,94
(men)
80–87 (women); 94–
101 (men)
88–95 (women); 102–
117 (men)
$96 (women); $118
(men) P for trend
Person-years 814,082 528,937 544,588 73,404
Number of deaths 7,611 5,529 6,631 1,206
Number of participants 93,212 60,898 62,987 8,616
Age-adjusted relative risk 1.0 1.06 (1.03–1.10) 1.28 (1.24–1.32) 1.92 (1.81–2.05) ,0.0001
Multivariate relative risk 1.0 1.11 (1.07–1.16) 1.29 (1.24–1.35) 1.68 (1.55–1.81) ,0.0001
Body mass index (kg/m
2) 18.5–24.9 25.0–29.9 30.0–34.9 $35.0
Person-years 778,409 836,885 269,391 76,326
Number of deaths 7,792 8,786 3,330 1,069
Number of participants 89,360 96,296 31,169 8,888
Age-adjusted relative risk 1.0 0.97 (0.94–0.99) 1.22 (1.17–1.27) 1.65 (1.54–1.75) ,0.0001
Multivariate relative risk 1.0 0.99 (0.96–1.02) 1.24 (1.19–1.29) 1.68 (1.57–1.79) ,0.0001
The multivariate models used person-time as the underlying time metric and included the following covariates: age at entry (continuous), sex (male, female), race/
ethnicity (white, black, Hispanic, Asian), smoking status (never, former, current), and alcohol intake (0, ,1, ,3, $3 drinks per day). The analysis of waist circumference
was additionally adjusted for body-mass index (18.5–24.9, 25.0–29.9, 30.0–34.9, $35.0 kg/m
2).
doi:10.1371/journal.pone.0018582.t001
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94 centimeters for men) served as the reference group.
Participants were divided into four BMI categories that
correspond to the definitions of normal weight (18.5 to 24.9
kg/m
2), overweight (25.0 to 29.9 kg/m
2), obesity class 1 (30.0 to
34.9 kg/m
2), and obesity classes 2 or 3 (35 kg/m
2 or greater)
proposed by the World Health Organization (WHO) [14]. The
group of subjects with a BMI of 18.5 to 24.9 kg/m
2 served as the
reference group.
Our categorizations of WC and BMI resulted in similar
fractions of the at-risk population in the lowest WC and BMI
categories and in similar fractions of the at-risk population in the
highest WC and BMI categories.
In large cohorts similar to ours, comparisons of self-reported and
measured WCs showed correlation coefficients of 0.89 in women
and 0.95 in men [15]. The correlations between self-reported as
compared with technician-measured BMI values have been found
to be in the area of 0.94 for women and 0.92 for men [16].
Statistical analysis
Cox proportional hazards regression [17] with person-time as
the time scale was used to estimate the relative risks and
Table 2. Relative risk of death from cancer according to waist circumference and body mass index.
Death from any cancer
Waist circumference (cm)
,80 (women); ,94
(men)
80–87 (women); 94–
101 (men)
88–95 (women);
102–117 (men)
$96 (women); $118
(men) P for trend
Person-years 814,082 528,937 544,579 73,404
Number of deaths 3,339 2,377 2,783 409
Age-adjusted relative risk 1.0 1.05 (0.99–1.11) 1.22 (1.16–1.28) 1.45 (1.30–1.60) ,0.0001
Multivariate relative risk 1.0 1.08 (1.02–1.14) 1.22 (1.14–1.30) 1.37 (1.21–1.56) ,0.0001
Body mass index (kg/m
2) 18.5–24.9 25.0–29.9 30.0–34.9 $35.0
Person-years 778,400 836,885 269,391 76,326
Number of deaths 3,405 3,780 1,377 346
Age-adjusted relative risk 1.0 0.98 (0.93–1.03) 1.17 (1.10–1.25) 1.18 (1.06–1.32) ,0.0001
Multivariate relative risk 1.0 1.01 (0.97–1.06) 1.22 (1.14–1.29) 1.25 (1.12–1.40) ,0.0001
Death from lung cancer
Waist circumference (cm)
,80 (women); ,94
(men)
80–87 (women); 94–
101 (men)
88–95 (women);
102–117 (men)
$96 (women); $118
(men)
Number of deaths 1,140 773 885 127
Multivariate relative risk 1.0 1.12 (1.02–1.24) 1.37 (1.23–1.53) 1.77 (1.41–2.23) ,0.0001
Body mass index (kg/m
2) 18.5–24.9 25.0–29.9 30.0–34.9 $35.0
Number of deaths 1,260 1,212 367 86
Multivariate relative risk 1.0 0.92 (0.85–0.99) 0.94 (0.83–1.05) 0.94 (0.75–1.17) ,0.16
Death from obesity-related cancers
Waist circumference (cm)
,80 (women); ,94
(men)
80–87 (women); 94–
101 (men)
88–95 (women);
102–117 (men)
$96 (women); $118
(men)
Number of deaths 837 599 800 117
Multivariate relative risk 1.0 0.99 (0.88–1.11) 1.11 (0.98–1.26) 1.10 (0.86–1.40) 0.25
Body mass index (kg/m
2) 18.5–24.9 25.0–29.9 30.0–34.9 $35.0
Number of deaths 837 973 433 110
Multivariate relative risk 1.0 1.15 (1.05–1.27) 1.63 (1.45–1.83) 1.52 (1.24–1.86) ,0.0001
Death from all other cancers
Waist circumference (cm)
,80 (women); ,94
(men)
80–87 (women); 94–
101 (men)
88–95 (women);
102–117 (men)
$96 (women); $118
(men)
Number of deaths 1,362 1,005 1,098 165
Multivariate relative risk 1.0 1.10 (1.00–1.20) 1.16 (1.05–1.29) 1.33 (1.08–1.63) ,0.0001
Body mass index (kg/m
2) 18.5–24.9 25.0–29.9 30.0–34.9 $35.0
Number of deaths 1,308 1,595 577 150
Multivariate relative risk 1.0 1.02 (0.95–1.09) 1.23 (1.10–1.35) 1.36 (1.15–1.61) 0.0008
The multivariate models used person-time as the underlying time metric and included the following covariates: age at entry (continuous), sex (male, female), race/
ethnicity (white, black, Hispanic, Asian), smoking status (never, former, current), and alcohol intake (0, ,1, ,3, $3 drinks per day). The analyses of waist circumference
were additionally adjusted for body-mass index (18.5–24.9, 25.0–29.9, 30.0–34.9, $35.0 kg/m
2). Obesity-related cancers include colon cancer, breast cancer, esophageal
cancer, uterine cancer, ovarian cancer, kidney cancer, and pancreatic cancer.
doi:10.1371/journal.pone.0018582.t002
Waist, Body-Mass Index and Mortality
PLoS ONE | www.plosone.org 3 April 2011 | Volume 6 | Issue 4 | e18582corresponding 95 percent confidence intervals of death. Follow-up
time was calculated from the return date of the second
questionnaire until death from any cause or the end of study in
December 31, 2005, whichever occurred first. Tests of the
proportional hazards assumptions for exposures and covariates
included in our models indicated no departures. Tests of linear
trend were conducted by modeling the median values of WC or
BMI categories as a single continuous variable, the coefficient for
which was evaluated using a Wald test.
The multivariate models were adjusted for age, gender, race/
ethnicity, smoking status, and alcohol intake. We did not adjust for
physical activity because physical activity is an important determinant
of body weight. We considered education level as a potential
confounder but did not retain that variable in the final model because
it failed to substantially alter beta coefficients in our primary
exposures. The analyses of WC were additionally adjusted for BMI,
thereby producing a variable reflecting mainly abdominal fat depots.
We tested for and found no effect modification by gender and
therefore show results for women and men combined. All reported P
values are based on two-sided hypothesis tests. Statistical analyses
were conducted using SAS version 9.1 (SAS Institute, Cary, NC).
Results
During 1,961,011 person-years of follow-up, we documented
20,977 deaths. The mean (SD) ages at study entry and end of
follow-up were 62.9 (5.3) and 71.7 (5.3) years, respectively. For
men, the minimum and maximum WC sizes were 69.2 and
136.5 cm, respectively. For women, the minimum and maximum
WC sizes were 50.8 and 138.4 cm, respectively. WC was positively
correlated with BMI (r=0.72). Participants with large WC or
those with high BMI tended to have lower education levels, they
were less likely to currently smoke, and they consumed less alcohol
than their lean counterparts (data not shown).
Risk of death from any cause increased monotonically with
higher values of WC (Table 1). Using participants with normal
WC as the reference group, women with WC of 96 centimeters or
higher and men with WC of 118 centimeters or higher showed a
nearly 70 percent increased risk of death from any cause
(multivariate relative risk=1.68; 95 percent confidence interval,
1.55 to 1.81; P for trend,0.0001). The relation of BMI to death
from any cause was of similar magnitude as that with WC. As
compared with normal BMI, the multivariate relative risk of death
Table 3. Relative risk of death from cardiovascular disease according to waist circumference and body mass index.
Death from any cardiovascular disease
Waist circumference (cm)
,80 (women); ,94
(men)
80–87 (women); 94–
101 (men)
88–95 (women); 102–
117 (men)
$96 (women); $118
(men) P for trend
Person-years 814,082 528,937 544,579 73,404
Number of deaths 2,241 1,818 2,149 460
Age-adjusted relative risk 1.0 1.18 (1.11–1.26) 1.42 (1.34–1.51) 2.60 (2.35–2.88) ,0.0001
Multivariate relative risk 1.0 1.17 (1.09–1.25) 1.28 (1.18–1.38) 1.82 (1.59–2.08) ,0.0001
Body mass index (kg/m
2) 18.5–24.9 25.0–29.9 30.0–34.9 $35.0
Person-years 778,400 836,885 269,391 76,326
Number of deaths 2,160 2,922 1,173 413
Age-adjusted relative risk 1.0 1.11 (1.05–1.18) 1.52 (1.42–1.63) 2.37 (2.13–2.63) ,0.0001
Multivariate relative risk 1.0 1.14 (1.08–1.21) 1.53 (1.43–1.65) 2.37 (2.13–2.64) ,0.0001
Death from coronary heart disease
Waist circumference (cm)
,80 (women); ,94
(men)
80–87 (women); 94–
101 (men)
88–95 (women); 102–
117 (men)
$96 (women); $118
(men)
Number of deaths 1,405 1,105 1,293 270
Multivariate relative risk 1.0 1.10 (1.01–1.20) 1.18 (1.07–1.30) 1.64 (1.38–1.95) ,0.0001
Body mass index (kg/m
2) 18.5–24.9 25.0–29.9 30.0–34.9 $35.0
Number of deaths 1,263 1,833 734 243
Multivariate relative risk 1.0 1.18 (1.10–1.27) 1.59 (1.45–1.74) 2.38 (2.07–2.73) ,0.0001
Death from other cardiovascular disease
Waist circumference (cm)
,80 (women); ,94
(men)
80–87 (women); 94–
101 (men)
88–95 (women); 102–
117 (men)
$96 (women); $118
(men)
Number of deaths 836 713 856 190
Multivariate relative risk 1.0 1.28 (1.15–1.42) 1.45 (1.28–1.64) 2.15 (1.74–2.65) ,0.0001
Body mass index (kg/m
2) 18.5–24.9 25.0–29.9 30.0–34.9 $35.0
Number of deaths 897 1,089 439 170
Multivariate relative risk 1.0 1.08 (0.99–1.18) 1.44 (1.29–1.62) 2.35 (1.99–2.78) ,0.0001
The multivariate models used person-time as the underlying time metric and included the following covariates: age at entry (continuous), sex (male, female), race/
ethnicity (white, black, Hispanic, Asian), smoking status (never, former, current), and alcohol intake (0, ,1, ,3, $3 drinks per day). The analyses of waist circumference
were additionally adjusted for body-mass index (18.5–24.9, 25.0–29.9, 30.0–34.9, $35.0 kg/m
2).
doi:10.1371/journal.pone.0018582.t003
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confidence interval, 1.57 to 1.79, P for trend,0.0001).
WC wassignificantlypositively associated withdeathfromcancer,
most notably death from lung cancer (Table 2). The multivariate
relative risk of lung cancer death comparing extreme categories of
WC was 1.77 (95 percent confidence interval, 1.41 to 2.23, P for
trend,0.0001). In contrast, the risk estimates relating BMI to death
from lung cancer were below unity and the BMI category
representing overweight showed a statistically significant inverse
association (multivariate relative risk as compared with normal
weight=0.92; 95 percent confidence interval, 0.85 to 0.99). The P
value for the test for trend was statistically non-significant at 0.16.
Both WC and BMI were significantly positively related to death
from cardiovascular disease (Table 3). The positive relations of
high versus low categories of WC to death from any cardiovascular
disease, death from coronary heart disease, and death from other
cardiovascular disease (including death from stroke) were 23
percent, 31 percent, and 9 percent weaker, respectively, than those
with high versus low categories of BMI.
WC showed a monotonically positive association with death
from non-cancer/non-cardiovascular disease, particularly death
from chronic respiratory disease (Table 4). The multivariate
relative risk of death from chronic respiratory disease comparing
extreme categories of WC was 2.77 (95 percent confidence
interval, 1.95 to 3.95; P for trend,0.0001). By comparison, BMI
showed a J-shaped relation with death from chronic respiratory
disease, with strong inverse associations for overweight and class 1
obesity and a weak, statistically non-significant positive relation for
the combination of classes 2 and 3 obesity (multivariate relative
risk compared with normal weight=1.18; 95 percent confidence
interval, 0.89 to 1.56; P for inverse trend,0.0001). The only non-
cancer/non-cardiovascular death endpoint that showed no
statistically significant positive relation with WC was death from
injuries (multivariate relative risk=1.14; 95 percent confidence
interval, 0.70 to 1.87; P for trend=0.94) (Table 5).
We examined the combined effects of WC and BMI on risk of
death (Table 6). For this analysis, we collapsed the top two BMI
categories. In the group of participants with BMI values between
25.0 and 29.9 kg/m
2, high versus low WC predicted an increased
risk of death from any cause and death from specific causes.
Participants with BMI levels of 18.5 to 24.9 kg/m
2 also showed
positive relations of WC to risk of death from any cause and death
Table 4. Relative risk of death from any non-cancer/non-cardiovascular diseases and from selected non-cancer/non-cardiovascular
diseases according to waist circumference and body mass index.
Death from any non-cancer/non-cardiovascular disease
Waist circumference (cm)
,80 (women); ,94
(men)
80–87 (women); 94–101
(men)
88–95 (women); 102–
117 (men)
$96 (women); $118
(men) P for trend
Person-years 814,082 528,937 544,579 73,404
Number of deaths 2,031 1,334 1,699 337
Age-adjusted relative risk 1.0 0.96 (0.89–1.03) 1.22 (1.14–1.30) 2.01 (1.79–2.25) ,0.0001
Multivariate relative risk 1.0 1.10 (1.02–1.19) 1.46 (1.34–1.59) 2.03 (1.74–2.37) ,0.0001
Body mass index (kg/m
2) 18.5–24.9 25.0–29.9 30.0–34.9 $35.0
Person-years 778,400 836,885 269,391 76,326
Number of deaths 2,227 2,084 780 310
Age-adjusted relative risk 1.0 0.81 (0.76–0.86) 1.01 (0.93–1.09) 1.69 (1.49–1.89) ,0.0001
Multivariate relative risk 1.0 0.82 (0.77–0.87) 1.01 (0.93–1.09) 1.67 (1.48–1.88) ,0.0001
Death from chronic respiratory disease
Waist circumference (cm)
,80 (women); ,94
(men)
80–87 (women); 94–101
(men)
88–95 (women); 102–
117 (men)
$96 (women); $118
(men)
Number of deaths 490 254 317 66
Multivariate relative risk 1.0 1.07 (0.91–1.25) 1.71 (1.43–2.05) 2.77 (1.95–3.95) ,0.0001
Body mass index (kg/m
2) 18.5–24.9 25.0–29.9 30.0–34.9 $35.0
Number of deaths 635 326 111 55
Multivariate relative risk 1.0 0.49 (0.43–0.57) 0.56 (0.46–0.69) 1.18 (0.89–1.56) ,0.0001
Death from acute respiratory/infectious disease
Waist circumference (cm)
,80 (women); ,94
(men)
80–87 (women); 94–101
(men)
88–95 (women); 102–
117 (men)
$96 (women); $118
(men)
Number of deaths 227 164 184 36
Multivariate relative risk 1.0 1.18 (0.95–1.46) 1.37 (1.07–1.76) 2.20 (1.39–3.49) 0.0006
Body mass index (kg/m
2) 18.5–24.9 25.0–29.9 30.0–34.9 $35.0
Number of deaths 247 247 91 26
Multivariate relative risk 1.0 0.88 (0.73–1.05) 1.04 (0.82–1.33) 1.21 (0.81–1.82) 0.56
The multivariate models used person-time as the underlying time metric and included the following covariates: age at entry (continuous), sex (male, female), race/
ethnicity (white, black, Hispanic, Asian), smoking status (never, former, current), and alcohol intake (0, ,1, ,3, $3 drinks per day). The analyses of waist circumference
were additionally adjusted for body-mass index (18.5–24.9, 25.0–29.9, 30.0–34.9, $35.0 kg/m
2).
doi:10.1371/journal.pone.0018582.t004
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significance for the highest WC category and were statistically
significant only for the second to highest WC category. BMI levels
of 30.0 kg/m
2 or higher attenuated the positive relation of WC to
death.
Discussion
The primary findingof this large prospective investigationof over
225,000 women and men followed for nine years is that adiposity as
assessed by WC was strongly and consistently related to death from
a comprehensive list of death from major specific causes, including
deaths from lung cancer and chronic respiratory disease, indepen-
dent of BMI and other covariates. In contrast, adiposity as assessed
by BMI showed inconsistent associations with specific causes of
death, displaying positive relations to death from non-lung cancers,
cardiovascular disease, and non-cancer/non-cardiovascular diseas-
es, but inverse or null associations with deaths from lung cancer and
chronic respiratory disease. This finding indicates that an increased
amount of abdominal fat, but not general adiposity, represents a
consistent predictor of premature death from major specific causes.
Our results have significant clinical implications because they
suggest that WC represents a superior predictor than BMI of risk
of deaths from lung cancer and chronic respiratory disease, two
major causes of death. For example, obtaining a WC measure-
ment in individuals already at increased risk for respiratory death
(e.g., due to smoking or chronic obstructive respiratory disease)
provides important information not delivered by BMI on a
patient’s risk of premature mortality.
Though speculative, one possible biologic reason for the
heterogeneous associations of WC and BMI to mortality from
lung cancer and chronic respiratory disease is that lung cancer
mortality and chronic respiratory disease mortality may involve
biologic pathways related to insulin resistance and related
metabolic abnormalities, such as excess release of proinflammatory
and prothrombotic factors [18,19], which are more strongly
related to abdominal adiposity than to overall excess body weight.
An alternative explanation for the divergent relations of WC
and BMI to deaths from lung cancer and chronic respiratory
disease is heterogeneity with respect to residual confounding by
smoking. Current smoking is related to both lower BMI [20] and
increased mortality from lung cancer and chronic respiratory
disease. By comparison, current smoking is associated with visceral
fat accumulation [21] and smoking cessation is related to increases
in WC [22]. Limiting the investigation to participants who never
smoked helps resolve the issue of residual confounding by smoking
with respect to both BMI and WC but our cohort lacked sufficient
numbers of cases of mortality from lung cancer and chronic
respiratory disease among persons who never smoked.
To the best of our knowledge, no previous study has examined
the association between WC and risk of death from lung cancer.
Table 5. Relative risk of death from selected non-cancer/non-cardiovascular diseases according to waist circumference and body
mass index.
Death from diabetes and kidney disease
Waist circumference (cm)
,80 (women); ,94
(men)
80–87 (women); 94–
101 (men)
88–95 (women); 102–
117 (men)
$96 (women); $118
(men)
Number of deaths 191 142 270 75
Multivariate relative risk 1.0 1.03 (0.82–1.31) 1.64 (1.29–2.10) 2.42 (1.67–3.52) ,0.0001
Body mass index (kg/m
2) 18.5–24.9 25.0–29.9 30.0–34.9 $35.0
Number of deaths 174 273 154 77
Multivariate relative risk 1.0 1.26 (1.04–1.53) 2.29(1.84–2.85) 4.78 (3.64–6.27) ,0.0001
Death from injuries
Waist circumference (cm)
,80 (women); ,94
(men)
80–87 (women); 94–
101 (men)
88–95 (women); 102–
117 (men)
$96 (women); $118
(men)
Number of deaths 260 168 166 30
Multivariate relative risk 1.0 1.00 (0.81–1.23) 0.95 (0.74–1.22) 1.14 (0.70–1.87) 0.94
Body mass index (kg/m
2) 18.5–24.9 25.0–29.9 30.0–34.9 $35.0
Number of deaths 246 258 89 31
Multivariate relative risk 1.0 0.89 (0.74–1.06) 1.02 (0.79–1.30) 1.51 (1.03–2.19) 0.24
Death from other non-cancer/non-cardiovascular diseases
Waist circumference (cm)
,80 (women); ,94
(men)
80–87 (women); 94–
101 (men)
88–95 (women); 102–
117 (men)
$96 (women); $118
(men)
Number of deaths 863 606 762 130
Multivariate relative risk 1.0 1.13 (1.01–1.26) 1.48 (1.31–1.68) 1.91 (1.50–2.43) ,0.0001
Body mass index (kg/m
2) 18.5–24.9 25.0–29.9 30.0–34.9 $35.0
Number of deaths 925 980 335 121
Multivariate relative risk 1.0 0.92 (0.84–1.01) 1.04 (0.91–1.18) 1.56 (1.29–1.89) 0.006
The multivariate models used person-time as the underlying time metric and included the following covariates: age at entry (continuous), sex (male, female), race/
ethnicity (white, black, Hispanic, Asian), smoking status (never, former, current), and alcohol intake (0, ,1, ,3, $3 drinks per day). The analyses of waist circumference
were additionally adjusted for body-mass index (18.5–24.9, 25.0–29.9, 30.0–34.9, $35.0 kg/m
2).
doi:10.1371/journal.pone.0018582.t005
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epidemiologic investigations that have focused on lung cancer
incidence. For example, the Iowa Women’s Health Study found a
positive relation of WC (relative risk comparing extreme
categories=1.76; 95 percent confidence interval, 1.14 to 2.73) to
lung cancer incidence [23]. Similarly, the Women’s Health
Initiative observed positive relations of WC to lung cancer
incidence among current smokers (relative risk=1.56; 95 percent
confidence interval, 0.91 to 2.69) and former smokers (relative
risk=1.50; 95 percent confidence interval, 0.98 to 2.31) [24].
Our findings regarding the relation of BMI to lung cancer death
are strikingly consistent with recent data from a large pooled
analysis of 57 prospective studies [25]. In that analysis, each 5
kg/m
2 increment in BMI was associated with a relative risk of lung
cancer death of 0.71 (95 percent confidence interval, 0.63 to 0.79)
within the BMI range of 15 to 25 kg/m
2 and was associated with a
relative risk of lung cancer death of 0.98 (95 percent confidence
interval, 0.88 to 1.09) within the BMI range of 25 to 50 kg/m
2 [25].
Our results of a monotonically positive relation of WC to
respiratory death are comparable to recent data from the
European Prospective Investigation into Cancer and Nutrition
(EPIC) Study [26]. In that study, the relative risk of respiratory
death comparing extreme quintiles of WC among women was
2.95 (95 percent confidence interval, 1.52 to 5.70) and the
corresponding relative risk among men was 6.56 (95 percent
confidence interval, 3.60 to 11.96).
Our results of a J-shaped association between BMI and death
from chronic respiratory disease are comparable to the aforemen-
tioned pooled analysis of 57 prospective studies [25]. Each 5
kg/m
2 increase in BMI was related to a relative risk of respiratory
death of 0.31 (95 percent confidence interval, 0.28 to 0.35) within
the BMI range of 15 to 25 kg/m
2 and was related to a relative risk
of respiratory death of 1.20 (95 percent confidence interval, 1.07 to
1.34) within the BMI range of 25 to 50 kg/m
2 [25].
Notable strengths of our study include its prospective design, a
large number of deaths from specific causes, a high follow-up rate,
Table 6. Multivariate relative risk of death from any cause and death from specific causes according to joint categories of waist
circumference and body mass index.
Variable Waist circumference (cm)
,80 (women); ,94
(men)
80–87 (women); 94–101
(men)
88–95 (women);
102–117 (men) $96 (women); $118 (men)
Death from any cause
Person-years 575,301 160,084 42,325 690
Body mass index 18.5–24.9 1.0 1.11 (1.05–1.17) 1.37 (1.26–1.50) 1.65 (0.89–3.07)
Person-years 229,312 320,304 280,558 6,712
Body mass index 25.0–29.9 1.0 1.11 (1.05–1.17) 1.26 (1.19–1.34) 2.01 (1.67–2.42)
Person-years 9,468 48,550 221,696 66,001
Body mass index $30.0 1.0 0.89 (0.72–1.10) 1.09 (0.89–1.34) 1.49 (1.21–1.83)
Death from cancer
Body mass index 18.5–24.9 1.0 1.10 (1.02–1.20) 1.22 (1.06–1.40) 1.84 (0.76–4.42)
Body mass index 25.0–29.9 1.0 1.07 (0.98–1.16) 1.19 (1.09–1.30) 1.45 (1.06–1.98)
Body mass index $30.0 1.0 0.82 (0.59–1.13) 1.01 (0.75–1.37) 1.11 (0.81–1.52)
Death from cardiovascular disease
Body mass index 18.5–24.9 1.0 1.19 (1.08–1.32) 1.40 (1.19–1.66) 1.92 (0.62–5.96)
Body mass index 25.0–29.9 1.0 1.14 (1.04–1.25) 1.22 (1.11–1.35) 2.38 (1.74–3.25)
Body mass index $30.0 1.0 0.84 (0.59–1.19) 1.00 (0.72–1.38) 1.55 (1.11–2.16)
Death from non-cancer/non-cardiovascular
diseases
Body mass index 18.5–24.9 1.0 1.04 (0.94–1.15) 1.59 (1.37–1.85) 1.15 (0.29–4.60)
Body mass index 25.0–29.9 1.0 1.15 (1.02–1.29) 1.46 (1.30–1.65) 2.74 (1.95–3.87)
Body mass index $30.0 1.0 1.18 (0.71–1.97) 1.52 (0.94–2.47) 2.37 (1.45–3.87)
Death from lung cancer
Body mass index 18.5–24.9 1.0 1.09 (0.96–1.25) 1.32 (1.07–1.63) 3.06 (0.98–9.50)
Body mass index 25.0–29.9 1.0 1.19 (1.02–1.39) 1.38 (1.18–1.62) 1.84 (1.13–2.98)
Body mass index $30.0 1.0 0.83 (0.42–1.64) 1.15 (0.61–2.17) 1.40 (0.73–2.68)
Death from respiratory mortality
Body mass index 18.5–24.9 1.0 0.96 (0.79–1.17) 1.60 (1.22–2.08) -
Body mass index 25.0–29.9 1.0 1.58 (1.12–2.21) 2.38 (1.71–3.31) 3.20 (1.35–7.57)
Body mass index $30.0 1.0 0.64 (0.18–2.32) 1.19 (0.38–3.77) 2.36 (0.74–7.56)
The multivariate models used person-time as the underlying time metric and included the following covariates: age at entry (continuous), sex (male, female), race/
ethnicity (white, black, Hispanic, Asian), smoking status (never, former, current), and alcohol intake (0, ,1, ,3, $3 drinks per day). Participants with a waist
circumference of ,80 cm (women) or ,94 cm (men) served as the reference group.
doi:10.1371/journal.pone.0018582.t006
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Despite a number of advantageous aspects of our study, one
potential limitation is a low response rate to the second
questionnaire used to obtain WC information, which could have
resulted in selection bias if, for example WC was preferentially
missing for persons with high mortality risk. A further potential
limitation is that WC, weight, and height were assessed using self-
report, a method that is known to be imperfect. However, self-
reported BMI values and WC measures have been found to be
sufficiently precise for use in epidemiologic studies [15,16]. Self-
reported height and weight vary systematically with BMI [27], but
the importance of such bias is uncertain [28]. Taken together, it is
improbable that misclassification of self-reported WC, height, and
weight fully accounted for our finding of markedly divergent
relations of general and abdominal adiposity to risk for deaths
from lung cancer and chronic respiratory disease. We did not
evaluate the association between WC and mortality from chronic
lung disease according to smoking status because that topic is
beyond the scope of the present investigation. Future studies
should examine that relation.
We conclude that increased abdominal fat, but not general
adiposity is associated with elevated risk of a comprehensive list of
death from major specific causes, including deaths from lung
cancer and chronic respiratory disease. Based on our observational
epidemiologic data, deaths from lung cancer and chronic
respiratory disease may potentially be added to the list of causes
of death directly related to adiposity.
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